BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3686657)

  • 1. The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiency.
    Inaba S; Okochi K; Fukada K; Kinoshita S; Maeda Y; Yoshinari M
    Transfusion; 1987; 27(6):475-7. PubMed ID: 3686657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.
    Horiuchi T; Nishizaka H; Kojima T; Sawabe T; Niho Y; Schneider PM; Inaba S; Sakai K; Hayashi K; Hashimura C; Fukumori Y
    J Immunol; 1998 Feb; 160(3):1509-13. PubMed ID: 9570574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on C9 deficiency.
    Kitamura H; Nagaki K; Inai S
    J Clin Lab Immunol; 1981 Jul; 6(1):7-11. PubMed ID: 7265179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of systemic lupus erythematosus in late component (C9) complement deficiency].
    Takeda I; Igarashi S; Nishimaki T; Kasukawa R
    Ryumachi; 1994 Jun; 34(3):628-32. PubMed ID: 8052928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese complement C9 deficiency.
    Kira R; Ihara K; Takada H; Gondo K; Hara T
    Hum Genet; 1998 Jun; 102(6):605-10. PubMed ID: 9703418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.
    Kira R; Ihara K; Watanabe K; Kanemitsu S; Ahmed SU; Gondo K; Takeshita K; Hara T
    J Hum Genet; 1999; 44(2):109-11. PubMed ID: 10083734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan.
    Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H; Akagaki Y; Inai S
    Int Immunol; 1989; 1(1):85-9. PubMed ID: 2487678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.
    Miura T; Goto S; Iguchi S; Shimada H; Ueno M; Nishi S; Narita I
    Clin Exp Nephrol; 2011 Feb; 15(1):86-91. PubMed ID: 21057849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of complement C9 deficiency in Koreans.
    Kang HJ; Kim HS; Lee YK; Cho HC
    Ann Clin Lab Sci; 2005; 35(2):144-8. PubMed ID: 15943177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-incidence of C9 deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan.
    Hayama K; Sugai N; Tanaka S; Lee S; Kikuchi H; Ito J; Suzuki J; Nagata Y; Kondo H; Harayama O
    Int Arch Allergy Appl Immunol; 1989; 90(4):400-4. PubMed ID: 2613346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biotin-avidin sandwich ELISA for quantification of intact complement component C9. The sera from hereditary C9 deficient individuals completely lack C9.
    Takata Y; Moriyama T; Fukumori Y; Yoden A; Shima M; Inai S
    J Immunol Methods; 1989 Feb; 117(1):107-13. PubMed ID: 2913155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary complement (C9) deficiency associated with dermatomyositis.
    Ichikawa E; Furuta J; Kawachi Y; Imakado S; Otsuka F
    Br J Dermatol; 2001 May; 144(5):1080-3. PubMed ID: 11359403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement.
    Fine DP; Gewurz H; Griffiss M; Lint TF
    Clin Immunol Immunopathol; 1983 Sep; 28(3):413-7. PubMed ID: 6883811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7, and C9 components.
    Alvarez V; Coto E; Setién F; Spath PJ; López-Larrea C
    Am J Med Genet; 1995 Feb; 55(4):408-13. PubMed ID: 7762578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement component 9 deficiency is not a susceptibility factor for SLE.
    Kanemitsu S; Ihara K; Kira R; Kaku Y; Sakai K; Tsuzaka K; Takeuchi T; Hara T
    Lupus; 2000; 9(6):456-7. PubMed ID: 10981651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal nocturnal haemoglobinuria with coexisting deficiency of the ninth component of complement: lack of massive haemolytic attack.
    Yonemura Y; Kawakita M; Koito A; Kawaguchi T; Nakakuma H; Kagimoto T; Schichishima T; Terasawa T; Akagaki Y; Inai S
    Br J Haematol; 1990 Jan; 74(1):108-13. PubMed ID: 2310692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing of the nt343C>T (R95X) allele of the C9 gene by PCR-SSP and the allele frequency of R95X in five ethnic populations.
    Tsujimura R; Nishimukai H; Okiura T; Fukumori Y; Tanabe R; Orimoto C; Ueda N
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S482-3. PubMed ID: 19261509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLE-like and sicca symptoms in late component (C9) complement deficiency.
    Sugimoto M; Nishikai M; Sato A; Suzuki Y; Nihei M; Uchida J; Mimura N
    Ann Rheum Dis; 1987 Feb; 46(2):153-5. PubMed ID: 3827337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.